About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 22 Issue 5 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2130 results:


Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study

Benoît Trottier, Jordan E Lake, Ken Logue, Cynthia Brinson, Lizette Santiago, Clare Brennan, Justin A Koteff, Brian Wynne, Judy Hopking, Catherine Granier, Michael Aboud

Antiviral Therapy 2017; 22:459-460


Correction: Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

Hussien Ahmed, Ahmed Elgebaly, Abdelrahman Ibrahim Abushouk, Ali Mohamed Hammad, Attia Attia, Ahmed Negida

Antiviral Therapy 2017; 22:457

Case report

Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution?

Agostino Riva, Alessandro Invernizzi, Chiara Resnati, Valeria Micheli, Dario Cattaneo, Cristina Gervasoni

Antiviral Therapy 2017; 22:453-455

Short communication

Prevalence of sofosbuvir resistance-associated variants in Brazilian and worldwide NS5B sequences of genotype-1 HCV

Allan Peres-da-Silva, Carlos Eduardo Brandão-Mello, Elisabeth Lampe

Antiviral Therapy 2017; 22:447-451

Short communication

Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate

Nicolas Margot, Stephanie Cox, Moupali Das, Scott McCallister, Michael D Miller, Christian Callebaut

Antiviral Therapy 2017; 22:443-446

Original article

HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients

Yael Gozlan, Ziv Ben-Ari, Roy Moscona, Rachel Shirazi, Aviya Rakovsky, Arij Kabat, Ella Veizman, Tania Berdichevski, Peretz Weiss, Oranit Cohen-Ezra, Yoav Lurie, Inna Gafanovich, Marius Braun, Michal Cohen-Naftaly, Amir Shlomai, Oren Shibolet, Ehud Zigmond, Eli Zuckerman, Michal Carmiel-Haggai, Assy Nimer, Rawi Hazzan, Yaakov Maor, Yona Kitay-Cohen, Yonat Shemer-Avni, Zipi Kra-Oz, Licita Schreiber, Ofer Peleg, Saleta Sierra, P Richard Harrigan, Ella Mendelson, Orna Mor

Antiviral Therapy 2017; 22:431-441

Original article

Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study

Vasantha Jotwani, Rebecca Scherzer, Michelle M Estrella, Lisa P Jacobson, Mallory D Witt, Frank Palella, Ken Ho, Michael Bennett, Chirag R Parikh, Joachim H Ix, Michael Shlipak

Antiviral Therapy 2017; 22:421-429

Original article

Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256

Huiling Yang, Chris Yang, Yujin Wang, Gerry Rhodes, Margaret Robinson, Guofeng Cheng, Xiaoping Qi, Hongmei Mo, Yang Tian, Rowchanak Pakdaman, X Christopher Sheng, Choung U Kim, William E Delaney

Antiviral Therapy 2017; 22:413-420

Original article

Increases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada

Mimi Tran, Evan Wood, Thomas Kerr, Sophie Patterson, David Bangsberg, Huiru Dong, Silvia Guillemi, Julio SG Montaner, M-J Milloy

Antiviral Therapy 2017; 22:403-411

Original article

Life expectancy after initiation of combination antiretroviral therapy in Thailand

Sirinya Teeraananchai, Suchada Chaivooth, Stephen J Kerr, Sorakij Bhakeecheep, Anchalee Avihingsanon, Achara Teeraratkul, Petchsri Sirinirund, Matthew G Law, Kiat Ruxrungtham

Antiviral Therapy 2017; 22:393-402

Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.